1 K-Drug Approved For Adjuvant Treatment Of Early-Stage Non-Small Cell Lung Cancer, Significantly Extending Cancer-Free Survival Of Patients! Nov 21, 2024
5 J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer Oct 23, 2024
6 Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For Oct 03, 2024
Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! Nov 17, 2024
Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Nov 03, 2024
